Biocon Limited has informed the Exchange regarding Change in Director(s) of the company.
BIOCON · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Biocon Limited informed the stock exchanges about two director re-appointments approved by shareholders at its 47th AGM held on August 8, 2025. Prof. Ravi Rasendra Mazumdar (brother of Biocon founder Kiran Mazumdar-Shaw) was re-appointed as a Director liable to retire by rotation. Ms. Naina Lal Kidwai, a Padma Shri awardee and former HSBC India Chairperson, was re-appointed as an Independent Director for a second 5-year term running from August 8, 2025 to August 7, 2030. The filing also confirmed that neither director is debarred from holding office by SEBI or any other authority. The intimation was signed by Ekta Agarwal, Interim Company Secretary.
This is a routine corporate governance update with no material effect on operations or financials. Shareholders retain continuity on the board, including a promoter-family member and a high-profile independent director, which generally supports stable oversight and investor confidence.